| LSSIX | WCMLX | LSSIX / WCMLX | |
| Total Expense Ratio | 0.93 | 0.99 | 94% |
| Annual Report Gross Expense Ratio | 0.93 | 1.79 | 52% |
| Fund Existence | 30 years | 7 years | - |
| Gain YTD | 23.019 | 13.517 | 170% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 100000 | 100% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.19B | 54.2M | 4,035% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 20.10 | 22.61 | 89% |
| Returns for 3 years | 30.77 | 28.03 | 110% |
| Returns for 5 years | -6.10 | 3.79 | -161% |
| Returns for 10 years | 59.95 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PABD | 68.51 | N/A | N/A |
| iSharesParis-AlgndClmOptdMSCIWldexUSAETF | |||
| ILOW | 45.37 | -0.35 | -0.77% |
| AB Active ETFs Inc. | |||
| SCDV | 27.27 | -0.23 | -0.84% |
| Bahl & Gaynor Small Cap Dividend ETF | |||
| XNTK | 357.98 | -10.88 | -2.95% |
| State Street® SPDR® NYSE Technology ETF | |||
| BBC | 51.34 | -1.82 | -3.43% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||